Works by Gurion, Ronit
Results: 55
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 483, doi. 10.1016/j.clml.2021.12.016
- By:
- Publication type:
- Article
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 24, doi. 10.1016/j.clml.2021.07.017
- By:
- Publication type:
- Article
ABCL-233: Febrile Neutropenia in Patients with Aggressive Large Cell Lymphoma and Diabetes Mellitus.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S383, doi. 10.1016/S2152-2650(21)01873-5
- By:
- Publication type:
- Article
AML-294: Maintenance Therapy After Allogeneic Hematopoietic Transplant for Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S302, doi. 10.1016/S2152-2650(21)01718-3
- By:
- Publication type:
- Article
Poster: ABCL-233: Febrile Neutropenia in Patients with Aggressive Large Cell Lymphoma and Diabetes Mellitus.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S240, doi. 10.1016/S2152-2650(21)01511-1
- By:
- Publication type:
- Article
Poster: AML-294: Maintenance Therapy After Allogeneic Hematopoietic Transplant for Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S216, doi. 10.1016/S2152-2650(21)01360-4
- By:
- Publication type:
- Article
A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S248, doi. 10.1016/j.clml.2019.07.153
- By:
- Publication type:
- Article
R-CHOP vs. R-CHOP+X for Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S243, doi. 10.1016/j.clml.2019.07.142
- By:
- Publication type:
- Article
Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Hypomethylating Agents-associated Infections-Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PET-CT Adapted Therapy for Advanced Hodgkin Lymphoma: A Systematic Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S320, doi. 10.1016/j.clml.2017.07.126
- By:
- Publication type:
- Article
Systematic Review and Meta-Analysis of Autologous Stem Cell Transplantation in Peripheral T Cell Lymphoma.
- Published in:
- Acta Haematologica, 2014, v. 131, n. 2, p. 112, doi. 10.1159/000354818
- By:
- Publication type:
- Article
The Use of Myeloid Colony-Stimulating Factors in Hematologic Malignancies: The Role of Systematic Reviews and Meta-Analyses.
- Published in:
- Acta Haematologica, 2011, v. 125, n. 1/2, p. 68, doi. 10.1159/000318898
- By:
- Publication type:
- Article
ATG plus Cyclosporine Reduces All-Cause Mortality in Patients with Severe Aplastic Anemia – Systematic Review and Meta-Analysis.
- Published in:
- Acta Haematologica, 2009, v. 120, n. 4, p. 237, doi. 10.1159/000203403
- By:
- Publication type:
- Article
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 3, p. 803, doi. 10.1007/s00277-023-05543-5
- By:
- Publication type:
- Article
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2127, doi. 10.1007/s00277-023-05306-2
- By:
- Publication type:
- Article
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents-a multicenter historical prospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma—a retrospective cohort study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 7, p. 2290, doi. 10.1007/s00259-022-05683-2
- By:
- Publication type:
- Article
Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia – an updated meta‐analysis.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 234, doi. 10.1111/bjh.15901
- By:
- Publication type:
- Article
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B‐Cell Lymphoma.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.70001
- By:
- Publication type:
- Article
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma—Outcomes indicative for improved survival overtime.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 838, doi. 10.1002/hon.3198
- By:
- Publication type:
- Article
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096
- By:
- Publication type:
- Article
Obinutuzumab-related adverse events: A systematic review and meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 584, doi. 10.1002/hon.2759
- By:
- Publication type:
- Article
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The role of maintenance therapy in patients with diffuse large B cell lymphoma: A systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Maintenance therapy after allogeneic hematopoietic transplant for acute myeloid leukemia: a systematic review and meta-analysis.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 10, p. 1335, doi. 10.1080/0284186X.2021.1955969
- By:
- Publication type:
- Article
R-CHOP compared to R-CHOP + X for newly diagnosed diffuse large B-cell lymphoma: a systematic review and meta-analysis.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 6, p. 744, doi. 10.1080/0284186X.2021.1898048
- By:
- Publication type:
- Article
PET-adapted therapy for advanced Hodgkin lymphoma -- systematic review.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 6, p. 765, doi. 10.1080/0284186X.2018.1426877
- By:
- Publication type:
- Article
First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response – systematic review and meta-analysis.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 9/10, p. 1077, doi. 10.1080/0284186X.2016.1201214
- By:
- Publication type:
- Article
Central nervous system involvement in T-cell lymphoma: A single center experience.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 5, p. 561, doi. 10.3109/0284186X.2015.1118656
- By:
- Publication type:
- Article
CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma – a meta-analysis of randomized controlled trials.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 1, p. 77, doi. 10.3109/0284186X.2015.1043025
- By:
- Publication type:
- Article
Primary cutaneous Υ/δ T-cell lymphoma. An atypical case with bone marrow granulomas.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
CAR‐T cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. e4, doi. 10.1111/bjh.18506
- By:
- Publication type:
- Article
Chimeric antigen receptor T‐cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 838, doi. 10.1111/bjh.18335
- By:
- Publication type:
- Article
High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients-Systematic review and meta-analysis.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 657, doi. 10.1002/ajh.22076
- By:
- Publication type:
- Article
Effect of steroid treatment on the diagnostic yield of baseline <sup>18</sup>f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00924-9
- By:
- Publication type:
- Article
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 149, doi. 10.1111/ejh.13884
- By:
- Publication type:
- Article
Infectious complications and long-term outcomes in patients with diffuse large B-Cell lymphoma and diabetes mellitus.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 14, p. 3378, doi. 10.1080/10428194.2022.2118526
- By:
- Publication type:
- Article
Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 10, p. 2461, doi. 10.1080/10428194.2022.2081325
- By:
- Publication type:
- Article
Late onset neutropenia after rituximab and obinutuzumab treatment – characteristics of a class-effect toxicity.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 12, p. 2921, doi. 10.1080/10428194.2021.1948037
- By:
- Publication type:
- Article
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 1, p. 118, doi. 10.1080/10428194.2020.1824069
- By:
- Publication type:
- Article
Recognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivors.
- Published in:
- Leukemia & Lymphoma, 2019, v. 60, n. 14, p. 3449, doi. 10.1080/10428194.2019.1641803
- By:
- Publication type:
- Article
Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma.
- Published in:
- Leukemia & Lymphoma, 2019, v. 60, n. 12, p. 2922, doi. 10.1080/10428194.2019.1620946
- By:
- Publication type:
- Article
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 5, p. 1163, doi. 10.1080/10428194.2017.1375102
- By:
- Publication type:
- Article